Moreover, it is necessary to take into account other complex matters such as the insurgence of immune responses against the restored protein (e.g., against dystrophin in DMD) or against viral elements (in gene therapy settings) that might appear at different times. This evidence concerns the gene DMD and Duchenne muscular dystrophy.